The investment seeks to maximize income while maintaining prospects for capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ModerateAllocation
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVIX | 10.10 | 0.06 | +0.60% |
American Century Small Cap Value Inv | |||
VSTSX | 300.61 | 1.32 | +0.44% |
Vanguard Total Stock Mkt Idx Instl Sel | |||
GSLLX | 23.27 | 0.09 | +0.39% |
Goldman Sachs Enhanced U.S. Equity Inv | |||
PXIIX | 22.47 | 0.07 | +0.31% |
Virtus KAR Equity Income I | |||
FBTTX | 25.58 | N/A | N/A |
Fidelity Advisor Biotechnology M |
A.I.dvisor indicates that over the last year, JNBCX has been closely correlated with BCICX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if JNBCX jumps, then BCICX could also see price increases.
Ticker / NAME | Correlation To JNBCX | 1D Price Change % | ||
---|---|---|---|---|
JNBCX | 100% | +0.10% | ||
BCICX - JNBCX | 93% Closely correlated | +0.10% | ||
BAICX - JNBCX | 92% Closely correlated | +0.10% | ||
BIICX - JNBCX | 92% Closely correlated | +0.10% | ||
BKMIX - JNBCX | 92% Closely correlated | +0.10% | ||
VSCGX - JNBCX | 85% Closely correlated | +0.14% | ||
More |